Cellectisの推定成長EPS Q/Q
Cellectisの推定成長EPS Q/Qは何ですか。
Cellectisの推定成長EPS Q/Qは-45.12%です。
推定成長EPS Q/Qの定義は何ですか。
期待される四半期ごとのEPS成長率は、過去四半期の業績と比較して、次の四半期の企業EPSの推定増加です。
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
NASDAQのセクタHealth Careにおける推定成長EPS Q/Qの企業と比べるCellectis
Cellectisは何をしますか。
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Cellectisと類似の推定成長eps q/q
- Banco Macro S.Aの推定成長EPS Q/Qは-45.38%です。
- American International Incの推定成長EPS Q/Qは-45.36%です。
- Western Unionの推定成長EPS Q/Qは-45.31%です。
- Passage Bio Incの推定成長EPS Q/Qは-45.26%です。
- Teradyneの推定成長EPS Q/Qは-45.26%です。
- Avanti Feedsの推定成長EPS Q/Qは-45.24%です。
- Cellectisの推定成長EPS Q/Qは-45.12%です。
- Companhia Siderurgica Nacionalの推定成長EPS Q/Qは-45.00%です。
- Copperleaf Technologiesの推定成長EPS Q/Qは-45.00%です。
- Unity Biotechnology Incの推定成長EPS Q/Qは-45.00%です。
- Nano Dimension Ltdの推定成長EPS Q/Qは-45.00%です。
- PLx Pharmaの推定成長EPS Q/Qは-45.00%です。
- BXPの推定成長EPS Q/Qは-44.92%です。